What is the role of tranexamic acid (TXA) during primary or revision shoulder arthroplasty (SA) in decreasing the risk of periprosthetic joint infection (PJI)?

Authors: Edward McFarland, José M. Mora, Jorge Rojas
RECOMMENDATION: There is no evidence to support routine use of TXA in patients undergoing shoulder arthroplasty for the prophylaxis of PJI.
LEVEL OF EVIDENCE: Limited
DELEGATE VOTE: Agree: 100%, Disagree: 0%, Abstain: 0% (Unanimous, Strongest Consensus)

s09